tokenengine.ai

Structured Product Evaluator

info@tokenengine.ai

8.20% p.a. Multi Barrier Reverse Convertible on Nestlé, Novartis & Roche (CHF)

ISIN CH1607597072 · SIX Symbol AIIETQ · Callable · Final Fixing 27/10/2028

Headline Simulation Results

+4.85%
Expected annualized return
18.34%
Probability of a negative return
−17.55%
99% confidence VaR (1 year)
+6.58%
Expected total return over holding period
18.81 months
Expected holding period (≈ 1.57 years)
Metric Result
Expected annualized return +4.85%
Probability of a negative return 18.34%
99% confidence VaR (1 year) −17.55%
Expected total return over holding period +6.58%
Expected holding period 18.81 months (≈1.57 years)

Over 10,000 simulations the note delivers a positive result in roughly four out of five paths, with an average annualized outcome of about 4.85%. The figure sits below the 8.20% headline coupon because gains are capped at par plus coupons, while the minority of paths (about 18%) that breach the 69% barrier absorb the full decline of the worst-performing stock — capped upside cannot offset those barrier-driven losses. In the worst 1% of scenarios the annualized return is −17.55% or lower.

Product at a Glance

Field Detail
Issuer / Guarantor Leonteq Securities AG (Guarantor: PostFinance Ltd)
Currency / Denomination CHF / CHF 1,000
Coupon 8.20% p.a. paid quarterly (CHF 20.50 per CHF 1,000)
Underlyings Nestlé (NESN), Novartis (NOVN), Roche (ROP) — worst-of
Barrier 69% of initial, continuous observation
Strike 100% of initial
Early redemption Issuer callable, quarterly from year 1
Maturity 27/10/2028
Upside Capped (maximum capital redemption = par)

How It Works (in plain language)

Key Statistics — Product vs Underlying

Metric Structured Product Underlying (equal-weight basket, total return)
Expected annualized return 4.85% 10.38%
Expected annualized volatility 6.89% 12.78%
Probability of loss 18.34% 22.03%
99% VaR (1 year, annualized) −17.55% −15.28%

The three constituents are high-quality Swiss defensive names (Nestlé 3.67% dividend yield, Novartis 2.87%, Roche 2.50%; ≈3.01% equal-weight basket yield). Over the simulated horizon the equal-weight basket returned ≈10.38% p.a. including dividends. The note trades most of that upside for a much smoother ride — but note that its deep-tail risk (99% VaR −17.55%) is actually slightly worse than the diversified basket, reflecting the worst-of structure.

Simulation Outcomes

The scatter below plots each path's product return against the underlying basket return over the same holding period; the dashed line is the 1:1 reference. The product's returns are capped (you can see the flat ceiling near +16%) while the downside tracks the basket once the barrier is breached.

Simulation outcomes
Simulation outcomes
Structured product annualized return distribution
Structured product annualized return distribution
Underlying annualized return distribution
Underlying annualized return distribution
Risk / return profile
Risk / return profile
Box plot comparison
Box plot comparison
Scenario probabilities
Scenario probabilities

Holding Period and Coupon Outcomes

The issuer call is the single biggest driver of the outcome distribution: roughly 51% of paths are called early (most at the first observation date, month 12), while 48.92% run to maturity. (Modelling note: the issuer is assumed to exercise its call on the first quarterly observation date at which the worst-performing stock is at or above its starting level.) Consequently the most frequent holding period is 1.0 year and the most common coupon count is 4 or 8.

Holding period distribution
Holding period distribution
Coupon count distribution
Coupon count distribution

Investment Commentary

Strengths
Considerations

Figures are model-based simulations for illustration only and are not a forecast or investment advice. Returns are shown annualized to two decimal places; the risk-free reference (1-year CHF) is approximately 0%.